Do Longevity Drugs Have Additive Benefits? | Brian Kennedy, Ph.D.

Transcript

If we just took a population of middle-aged healthy individuals Yeah. and we we could design an experiment where you had the placebo arm, the metformin arm, the rapamy arm, the SGLT2 inhibitor arm, and the GLP-1 agonist arm. What is your prediction in length of life or additional years of life given in that six arm study or whatever it is? I I thin... Read More